77.00
-0.52%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Draegerwerk AG & Co KGaA
Its shares trade on XETRA under the ticker DRW8.DE. It has been listed since 1 January 1979. In the fiscal year to 31 December 2025, it reported revenue of €3.48bn and net income of €139.5m. At that date it held total assets of €3.28bn and shareholders' equity of €1.63bn.
Draegerwerk AG & Co KGaA is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Luebeck, Schleswig-Holstein. Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The firm operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The firm has production sites in Europe, the Americas, Africa and Asia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Jan 1979
- Employees
- 15,441
- Website
- draeger.com ↗
Leadership
Pay as last reported
- Mr. Stefan DraegerChairman of the Executive Board€1.7m
- Mr. Christian FischerVice Chairman of the Supervisory Board, Employee Representative, since 2022€59,700
- Mr. Gert-Hartwig LescowVice Chairman of the Executive Board, Chief Financial Officer, Executive Board Member for IT€1.3m
- Dr. Reiner PiskeExecutive Board Member for Sales and Human Resources€1.0m
- Ms. Stefanie HirschExecutive Board Member, Chief Sustainability and Quality, since 2023€219,700
- Mr. Rainer KlugExecutive Board Member for Safety Division€1.3m
- Mr. Anton SchrofnerExecutive Board Member for Medical Division€952,100
- Ms. Maria DietzIndependent Chairman of the Supervisory Board€33,100
- Prof. Dr. Thorsten GrenzIndependent Member of the Supervisory Board€63,100
- Ms. Astrid HamkerIndependent Member of the Supervisory Board€33,100
- Mr. Frank RiemenspergerIndependent Member of the Supervisory Board€43,100
- Dr. Reinhard ZinkannIndependent Member of the Supervisory Board€33,100
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 76
- Environment
- 95
- Social
- 99
- Governance
- 34
- Direct emissions (scope 1)
- 31,865 t
- Energy emissions (scope 2)
- 17,902 t
- Value chain emissions (scope 3)
- 33,615 t
- Women in the workforce
- 29.4%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Draegerwerk AG & Co KGaA boasts several key strengths that contribute to its competitive edge in the market. Firstly, the company has a strong reputation for producing high-quality and innovative medical technology products. This reputation has been built over many years and is trusted by healthcare professionals globally.
- Additionally, Draegerwerk AG & Co KGaA has a well-established global presence, with a strong distribution network that allows it to reach customers in various regions. This extensive network enhances the company's ability to penetrate new markets and increase its market share.
Weaknesses
- Despite its strengths, Draegerwerk AG & Co KGaA also faces certain weaknesses that need to be addressed. One significant weakness is the company's relatively high production costs compared to some competitors. This could potentially limit its ability to offer competitive pricing, especially in price-sensitive markets.
- Another weakness is the reliance on a limited number of suppliers for certain components used in its products. Any disruptions in the supply chain could negatively impact production and lead to delays in meeting customer demand.
Opportunities
- Draegerwerk AG & Co KGaA operates in a rapidly evolving healthcare industry, which presents several opportunities for growth. The increasing global demand for advanced medical technology and equipment opens up new market segments for the company to explore.
- Furthermore, the rising focus on patient safety and infection control provides an opportunity for Draegerwerk AG & Co KGaA to develop and market innovative solutions that address these concerns. This can help the company differentiate itself from competitors and attract more customers.
Threats
- The healthcare industry is subject to various threats that Draegerwerk AG & Co KGaA needs to mitigate. One significant threat is intense competition from both established players and new entrants in the market. This competition can result in pricing pressures and a potential loss of market share.
- Additionally, stringent regulations and compliance requirements in the healthcare sector pose a challenge to the company. Adhering to these regulations can incur additional costs and complexity in product development and distribution processes.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.